Navigation Links
Dissectron Ultrasonic Aspirator

ProductsDissectron Ultrasonic Aspirator
Company Integra LifeSciences Corporation
Item Dissectron Ultrasonic Aspirator
Features The ultrasonic handpiece profile has been designed to allow outstanding visibility of the working area together with safety and precision. DISSECTRON Portable Unit is one of the most user-friendly ultrasonic surgical aspirators on the market outside the United States.
Description Dissectron ultrasonic aspirator, portable unit is an ultrasonic surgical aspirator for the fragmentation and emulsification of tissue available only outside the united states. Gathers in a very compact design all the technologies required for operating a high-end instrument.
Info Integra LifeSciences Corporation
Customer Service: (800) 654-2873

Related medicine products :

1. Ultrasonic Pachymeter UP-1000
2. Compact Ultrasonic Phacoemulsification System
3. cusa selector™ Ultrasonic Aspirator
4. CUSA Excel Ultrasonic Surgical Aspirator
5. OSCAR Ultrasonic Bone Cement Remover
6. Ultrasonic Pachometer
7. The Ultrasonic BioMicroscope (UBM P40)
8. The P45 Ultrasonic Workstation
9. UD-6000 Ultrasonic A/B Scanner and Biometer
10. UD-1000 Ultrasonic B-Scanner
11. DGH Pachette 3 Ultrasonic Pachymeter
Breaking Medicine Technology:Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 2Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 3Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 4Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 5Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 6Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 7Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 8Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 9Phase III Study Demonstrates INVEGA(R) SUSTENNA(TM) (paliperidone palmitate) Statistically Similar to RISPERDAL(R) CONSTA(R) (risperidone) Long-Acting Injection 10AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3Haemonetics Sets Date for First Quarter Fiscal Year 2010 Earnings Release 3A August 3 2009 51439 1Varian Medical Systems Management to Present at the Piper Jaffray Cancer Summit 51436 1Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders Advises Frost 26 Sullivan 51431 1Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders Advises Frost 26 Sullivan 51431 2Medical Imaging Modality Vendors Should Focus on Innovation and Alliances with Market Leaders Advises Frost 26 Sullivan 51431 3